Grossamide
CAS: 80510-06-1
Ref. 3D-FDA51006
| 1mg | 482.00 € | ||
| 5mg | 1,079.00 € | ||
| 10mg | 1,942.00 € | ||
| 25mg | 4,316.00 € | ||
| 50mg | 5,394.00 € |
Product Information
- 3-Benzofurancarboxamide, 2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-5-[(1E)-3-[[2-(4-hydroxyphenyl)ethyl]amino]-3-oxo-1-propen-1-yl]-7-methoxy-, (2R,3R)-rel-
- 3-Benzofurancarboxamide, 2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-5-[(1E)-3-[[2-(4-hydroxyphenyl)ethyl]amino]-3-oxo-1-propenyl]-7-methoxy-, (2R,3R)-rel-
- 3-Benzofurancarboxamide, 2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-5-[3-[[2-(4-hydroxyphenyl)ethyl]amino]-3-oxo-1-propenyl]-7-methoxy-, [2α,3β,5(E)]-
- NSC 359837
- rel-(2R,3R)-2,3-Dihydro-2-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-5-[(1E)-3-[[2-(4-hydroxyphenyl)ethyl]amino]-3-oxo-1-propen-1-yl]-7-methoxy-3-benzofurancarboxamide
Grossamide is a synthetic toll-like receptor (TLR) agonist that activates the immune system. It is used in nutrient solutions to stimulate plant growth. Grossamide has been shown to inhibit acetylcholinesterase, which is an enzyme that breaks down the neurotransmitter acetylcholine and can be used as a potential treatment for Alzheimer's disease. Grossamide has also been shown to have anti-cancer properties, including inhibiting prostate cancer cell growth and increasing tumor necrosis factor-α (TNF-α).
Chemical properties
Technical inquiry about: 3D-FDA51006 Grossamide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
